Stimulant Use Disorder

Understand the signs of stimulant use disorder, how clinicians diagnose it, and what treatment involves. Find practical questions for care and a clearer picture of recovery.

Jessica Miller is the Content Manager of Addiction HelpWritten by
Kent S. Hoffman, D.O. is a founder of Addiction HelpMedically reviewed by Kent S. Hoffman, D.O.
Last updated

Battling addiction & ready for help?

Find Treatment Now

What Stimulant Use Disorder Means

Stimulant use disorder is a pattern of stimulant use that causes significant problems or distress. It can involve cocaine, methamphetamine, or prescription stimulants. Trouble controlling use, repeated harm, and the place the drug takes in daily life matter. The amount used alone does not establish or rule out the diagnosis.[1]

You might keep taking more than planned, miss responsibilities while recovering from use, or want to stop but struggle to do so. These experiences deserve attention even if you are unsure what to call them. A clinician can help you understand the pattern and discuss treatment.[1]

When Stimulant Use Needs Urgent Help

Call 911 for chest pain, a seizure, severe overheating, sudden trouble speaking or moving, severe confusion, or immediate danger of self-harm. A person can be awake during a life-threatening stimulant overdose. Do not wait for them to lose consciousness.[2]

If someone cannot be woken or is breathing slowly or not at all, give naloxone if available and call 911. Naloxone reverses opioid overdose, including from fentanyl that may be mixed with stimulants. It does not reverse stimulant effects. Stay with the person if safe and follow the dispatcher’s instructions.[3][2]

Fast Facts About Stimulant Use Disorder

These distinctions can help you understand an assessment and the care available:

  • A diagnosis involves at least two of 11 diagnostic criteria, or signs clinicians assess, within 12 months, along with significant problems or distress. A clinician assesses the full picture.[1][4]
  • Tolerance, when the same amount has less effect, and withdrawal, symptoms after stopping or reducing use, do not count toward a substance use disorder diagnosis when they develop during appropriate medical treatment. Other concerning patterns still need assessment.[4]
  • Contingency management uses practical rewards for agreed treatment goals, such as test results showing no stimulant use. Research supports it as a treatment option.[1][5]
  • No medication is FDA-approved specifically for stimulant use disorder. Clinicians may consider medicines approved for other purposes, depending on the person and the evidence.[6][1]

How Clinicians Diagnose Stimulant Use Disorder

A diagnosis comes from a clinical assessment, not a urine test or a checklist score alone. A clinician asks how use has affected your life, considers other health conditions, and looks for a pattern over time. Symptoms such as poor sleep or anxiety may have more than one explanation.[4]

The diagnostic framework includes 11 criteria. At least two must occur within a 12-month period. The following descriptions explain the areas assessed rather than giving you a diagnosis:[1]

  • Difficulty controlling use. Taking more or using for longer than planned, repeatedly trying unsuccessfully to reduce use, spending substantial time obtaining or recovering from it, or having strong urges called cravings. These are four separate criteria.[1]
  • Disruption of daily life. Repeatedly falling behind on major responsibilities, continuing despite relationship problems related to use, or giving up important activities. These are three criteria. An example might be repeatedly missing work after a night of use.[1]
  • Continuing despite danger or harm. Repeated use in physically dangerous situations, or continued use despite knowing it causes or worsens a physical or mental-health problem. These are two criteria.[1]
  • Tolerance and withdrawal. Tolerance means needing more for a similar effect, or getting less effect from the same amount. Withdrawal means symptoms after stopping or reducing use, or using to relieve those symptoms. These are the final two criteria, with an exception for appropriate medical treatment.[1][4]

Clinicians use a diagnostic manual called the DSM-5-TR. It classifies the disorder as mild with two or three criteria, moderate with four or five, and severe with six or more.[4] “Mild” does not mean that an overdose or another serious harm cannot occur. The diagnosis and immediate safety risks require separate attention.[4][2]

How Prescribed Use and Dependence Differ From Addiction

A body can become accustomed to a medicine. Physical dependence means withdrawal can appear when use is reduced or stopped. That is different from the wider pattern of problems assessed for a use disorder. Tolerance and withdrawal that develop during appropriate medical treatment do not count toward that diagnosis.[1][4]

Having a prescription does not make other concerns irrelevant. If you are taking extra doses or continuing despite harm, discuss those events with your prescriber. Understanding prescription stimulant use means considering misuse and dependence alongside prescribed benefits.[1]

What to Bring to an Assessment

Write down a few recent examples rather than trying to choose the right medical words. These prompts can help organize the conversation:

  • What you take, where it comes from, and how your use has changed.
  • Times you used more than planned, tried to cut down, or missed responsibilities.
  • Changes in sleep, mood, appetite, physical health, or relationships.
  • Other medicines, alcohol, or drugs you use, and what you hope treatment will help you do.

This is preparation for a conversation, not a diagnostic test. An assessment should consider both substance use and other health needs.[1][4]

Why Stopping Stimulants Can Be Difficult

Repeated stimulant use can affect reward, motivation, and the way a person responds to reminders of the drug. Dopamine is one of the brain’s chemical messengers involved in these processes. It is not a tank that simply runs empty. Sleep, stress, health, and surroundings also matter when someone is trying to stop.[1][7]

A craving is a strong urge to use. For example, a particular place or routine may bring back the urge even after someone has decided to stop. Treatment can help a person recognize these situations and practice another response, rather than relying only on determination in the moment.[1]

What the Stimulant Crash Feels Like

After heavy use stops, people may feel exhausted, depressed, irritable, or unusually hungry. They may sleep much more or struggle to sleep. These are possible stimulant withdrawal symptoms. Some people use again to escape how bad they feel, which is one reason support during withdrawal matters.[1]

A small study followed 21 people receiving inpatient care for methamphetamine withdrawal.[8] Symptoms were strongest early and fell substantially during the first week, with further observation over three weeks. That describes this group in a supervised setting. It does not predict when every person will feel better or cover every stimulant.[8]

Tell a clinician about severe or continuing low mood, trouble sleeping, or thoughts of suicide. Do not assume you must wait for a withdrawal timetable to end before getting help. Call or text 988 for suicidal thoughts or a mental-health crisis. Call 911 for immediate danger.[1][9]

What Stimulant Use Disorder Treatment Involves

Treatment can combine help changing drug-use patterns with care for physical health, mental health, and everyday needs. The plan should reflect the stimulant involved, your symptoms, your goals, and the support available. An outpatient program means attending appointments while living elsewhere. Some people need a more supervised setting.[1]

How Contingency Management Works

Contingency management provides agreed rewards, such as vouchers or prizes, when a person meets a treatment goal. In stimulant treatment, a goal is often a test result showing no use of the stimulant. This gives progress an immediate, practical benefit alongside longer-term goals.[1]

A 2020 systematic review included 27 methamphetamine studies. Of the 21 that reported abstinence outcomes, 20 found a benefit from contingency management. Abstinence means not using the substance being treated. That result counts studies, not people. It does not mean that 20 out of every 21 patients will stop using.[5]

A smaller South African pilot involved 30 adults over eight weeks.[10] About 63% met its response measure of at least 23 methamphetamine-negative results across 24 scheduled urine tests.[10] This adds evidence from a different setting, but a small pilot is not proof that all programs or populations get the same results.[10]

Access remains uneven. A 2023 review described barriers to offering contingency management widely, despite supporting research. When contacting a clinic, ask whether it actually provides the program, how often visits occur, and what happens if you miss a visit or a test shows use.[11]

Comparing Treatment Approaches

These approaches do different jobs and may be combined. The questions below can help you understand what a program offers beyond the label “addiction treatment.”[1]

Approach What Happens What to Ask
Contingency management Agreed rewards follow measurable goals, commonly stimulant-negative tests.[1] What are the goals, visit schedule, and rewards? How will care continue after the program ends?
Cognitive behavioral therapy (CBT) A therapist helps you notice patterns and practice responses to cravings. For example, you might plan what to do when a friend offers a drug after work.[1] Will sessions include practice for the situations where I usually use?
Behavioral activation You plan manageable activities that provide meaning or enjoyment without drug use, rather than waiting to feel motivated first.[7][1] Can we start with activities that fit my energy, money, and daily responsibilities?
Medication considered off-label A clinician may prescribe a medicine for a purpose outside its FDA-approved uses. The choice depends on the person, risks, and available evidence.[1] What benefit are we aiming for? What side effects and follow-up should I expect?

What Medication Research Can Tell You

There is currently no FDA-approved medication specifically for stimulant use disorder. That does not mean medication has no place in care. A clinician may consider an off-label option or treat another condition alongside it. Evidence from methamphetamine treatment should not automatically be applied to cocaine or prescription-stimulant problems.[6][1]

A 2018 review of 21 publications on medication combined with contingency management found mixed results. Some combinations helped more than comparison treatments, while others did not show a difference. This supports asking about the specific medicine and goal rather than assuming that adding any medicine improves treatment.[12]

A 2026 Australian trial in adults with moderate to severe methamphetamine use disorder compared mirtazapine, an antidepressant, with an inactive placebo pill. At 12 weeks, the medication group reduced use by about two more days per 28 days. Drowsiness, weight gain, and treatment discontinuation were more common with the medicine.[13]

The trial did not find significant benefits on its other measured outcomes, including mood and sleep. It offers a possible treatment discussion, not a promise of abstinence or a reason to take someone else’s medicine. A prescriber should explain how the potential benefits and harms apply to you.[13]

Treating Other Health Needs Alongside Stimulant Use

Care should include problems such as depression, anxiety, poor sleep, and physical illness. Symptoms can overlap with intoxication or withdrawal, so assessment matters. You do not have to work out which condition caused everything before describing what you are experiencing.[4][1]

In a published UNSW report about the methamphetamine medication trial, addiction psychiatrist Shalini Arunogiri described a treatment conversation as “an opportunity to address their other healthcare needs.” That is a useful reason to mention concerns beyond drug use when making an appointment.[14]

Understanding Psychosis, Hallucinations, and Paranoia

Psychosis means difficulty telling what is real. It can include hallucinations, such as hearing a voice others do not hear, or strongly held beliefs that are not based in reality. Paranoia can involve believing someone intends to harm you despite little or no evidence. Stimulant use can cause these symptoms, but other conditions can too.[1][15]

New symptoms need prompt medical assessment, especially when a person is frightened, confused, or behaving unsafely. Clinicians consider drug use, sleep, timing, and other possible causes. Do not assume that every symptom will disappear once the drug wears off. Methamphetamine-related psychosis may need treatment beyond the immediate effects of use.[1][15]

Why Opioid Exposure Also Matters

Stimulants and opioids can be used together, and an illicit stimulant supply may contain fentanyl. Tell a provider about all substances that might be involved. Ask about naloxone, the medicine that can reverse an opioid overdose. It does not treat a stimulant overdose.[2]

What Recovery Can Look Like

Recovery can involve changes in use, health, relationships, and daily functioning. Cravings or a return to use are reasons to review the plan and support available. Persistent low mood or sleep problems deserve care in their own right. There is no single recovery timetable that describes everyone.[1]

Why a Brain Scan Is Not a Recovery Clock

One small imaging study examined dopamine transporters, proteins involved in handling dopamine signals. Nine people who remained off methamphetamine returned for scans about nine months later. Transporter availability increased, but the study’s measure of dopamine release did not change.[16]

That finding does not establish a nine-month “brain reset,” prove that brain cells regrew, or tell someone when low mood will lift. It describes a particular marker in a small methamphetamine sample. Your symptoms and daily functioning are more useful things to discuss with your treatment team than trying to meet that deadline.[16][1]

Finding Stimulant Treatment Near You or Online

Start with a primary care clinician, an addiction specialist, or a treatment program. Ask specifically about stimulant use disorder. A general therapy appointment may be helpful, but confirm whether the service provides the assessment, treatment, and medical coordination you need.[1]

Questions to Ask Before Booking

Before choosing a provider, ask how their services would fit your needs:

  • Do you treat the stimulant I use, and do you offer contingency management or CBT?
  • Can you assess withdrawal, low mood, sleep problems, and medication needs?
  • Which visits can happen online, and which require in-person assessment or testing?
  • What will treatment cost, what does my insurance cover, and when can I be seen?
  • Who should I contact if symptoms worsen between appointments?

Use the answers to compare what services you would receive. Availability, costs, and remote-care arrangements must be confirmed with the provider.

Search FindTreatment.gov for services by location, or call SAMHSA’s National Helpline at 1-800-662-4357 for treatment referrals. Veterans can also ask their VA care team about stimulant treatment.[6][1]

If you are considering online therapy, confirm that the service can address your concerns and coordinate any medical care you need. You can also learn about the effects and risks of stimulants. Related guides cover cocaine, methamphetamine, crack cocaine, prescription stimulants, and bath salts.

If you are thinking about suicide or facing a mental-health crisis, call or text 988. For immediate danger or signs of overdose, call 911.[9][2]

Frequently asked questions

What Is Stimulant Use Disorder?

Stimulant use disorder is a pattern of use that causes significant problems or distress. It can involve cocaine, methamphetamine, or prescription stimulants. Clinicians assess 11 criteria, including trouble controlling use and continuing despite harm. At least two must occur within 12 months. Amount used alone does not determine the diagnosis.[1]

How Do I Know if I Have a Stimulant Problem?

Pay attention to taking more than planned, unsuccessful attempts to cut down, cravings, missed responsibilities, or continued use despite problems. Bring concrete examples to a clinician. A symptom list cannot diagnose you, and tolerance or withdrawal during appropriate medical treatment does not count toward a substance use disorder diagnosis.[1][4]

Why Can Stopping Stimulants Be So Difficult?

Cravings, reminders of use, withdrawal symptoms, stress, and other health needs can make stopping difficult. Stimulants affect brain processes involved in reward and motivation, but there is no single explanation for every person. Treatment can help you manage these difficulties and practice responses to situations where you usually use.[1][7]

Is There Medication for Stimulant Addiction?

No medication is FDA-approved specifically for stimulant use disorder. A clinician may consider a medicine off-label, meaning for a purpose outside its approved uses, or treat another condition alongside it. Evidence varies by medicine and stimulant. Ask about the intended benefit, side effects, and how medication fits with behavioral treatment.[6][1]

Does Contingency Management Work?

Research supports contingency management, which gives practical rewards for agreed treatment goals, often tests showing no stimulant use. A methamphetamine review found benefits in 20 of 21 studies reporting abstinence outcomes. That is a count of studies, not a patient success rate. Results and access vary, so ask what a specific program provides.[5][11][1]

Does the Brain Recover After Stimulant Addiction?

Some brain measures can change after stopping use, but a scan cannot predict one person’s recovery. In a small methamphetamine study, transporter availability improved at nine months while measured dopamine release did not change. This is not a nine-month recovery deadline. Seek care for continuing mood, sleep, or concentration problems rather than waiting for a supposed reset.[16][1]

Get Treatment Help

If you or someone you love is struggling with addiction, getting help is just a phone call away, or consider trying therapy online with BetterHelp.

Exclusive offer: 20% Off BetterHelp*

Following links to the BetterHelp website may earn us a commission that helps us manage and maintain AddictionHelp.com. *Get 20% off your first month of BetterHelp. Offer valid for new BetterHelp users only. Offer cannot be combined with insurance.

16 Sources
  1. Substance Abuse and Mental Health Services Administration. (2021). Treatment for stimulant use disorders (Treatment Improvement Protocol Series 33). Read source
  2. Centers for Disease Control and Prevention. (2022). A stimulant guide: Answers to emerging questions about stimulants in the context of the overdose epidemic in the United States. Read source
  3. Centers for Disease Control and Prevention. (2024, April 2). What to do if you think someone is overdosing. Read source
  4. New York State Department of Health AIDS Institute. (2024, May 30). Substance use screening, risk assessment, and use disorder diagnosis in adults. Read source
  5. Brown, H. D., & DeFulio, A. (2020). Contingency management for the treatment of methamphetamine use disorder: A systematic review. Drug and Alcohol Dependence, 216, 108307. https://doi.org/10.1016/j.drugalcdep.2020.108307 Read source
  6. U.S. Department of Veterans Affairs. (2025, September 18). Stimulant use disorder: Addiction treatment for Veterans. Read source
  7. Paulus, M. P., & Stewart, J. L. (2020). Neurobiology, clinical presentation, and treatment of methamphetamine use disorder: A review. JAMA Psychiatry, 77(9), 959–966. https://doi.org/10.1001/jamapsychiatry.2020.0246 Read source
  8. McGregor, C., Srisurapanont, M., Jittiwutikarn, J., Laobhripatr, S., Wongtan, T., & White, J. M. (2005). The nature, time course and severity of methamphetamine withdrawal. Addiction, 100(9), 1320–1329. https://doi.org/10.1111/j.1360-0443.2005.01160.x Read source
  9. 988 Suicide & Crisis Lifeline. (n.d.). 988 Lifeline. Read source
  10. Okafor, C. N., Stein, D. J., Dannatt, L., Ipser, J., van Nunen, L. J., Lake, M. T., Krishnamurti, T., London, E. D., & Shoptaw, S. (2020). Contingency management treatment for methamphetamine use disorder in South Africa. Drug and Alcohol Review, 39(3), 216–222. https://doi.org/10.1111/dar.13019 Read source
  11. Rawson, R. A., Erath, T. G., Chalk, M., Clark, H. W., McDaid, C., Wattenberg, S. A., Roll, J. M., McDonell, M. G., Parent, S., & Freese, T. E. (2023). Contingency management for stimulant use disorder: Progress, challenges, and recommendations. The Journal of Ambulatory Care Management, 46(2), 152–159. https://doi.org/10.1097/JAC.0000000000000450 Read source
  12. Tardelli, V. S., Lago, M. P. P. D., Mendez, M., Bisaga, A., & Fidalgo, T. M. (2018). Contingency management with pharmacologic treatment for stimulant use disorders: A review. Behaviour Research and Therapy, 111, 57–63. https://doi.org/10.1016/j.brat.2018.10.002 Read source
  13. McKetin, R., Shoptaw, S., Saunders, L., Nguyen, L., Clare, P. J., Dore, G. J., Turner, A., Dean, O. M., Kelly, P. J., Arunogiri, S., Koeijers, J., Degan, T. J., Degenhardt, L., Farrell, M., Goodman-Meza, D., Sinclair, B., Reid, D., Cordaro, F., Hill, H., … Berk, M. (2026). Mirtazapine for methamphetamine use disorder: A randomized clinical trial. JAMA Psychiatry, 83(6), 581–589. https://doi.org/10.1001/jamapsychiatry.2026.0159 Read source
  14. UNSW Sydney. (2026, April 2). Antidepressant offers fresh hope for people looking to reduce methamphetamine use. Read source
  15. Chiang, M., Lombardi, D., Du, J., Makrum, U., Sitthichai, R., Harrington, A., Shukair, N., Zhao, M., & Fan, X. (2019). Methamphetamine-associated psychosis: Clinical presentation, biological basis, and treatment options. Human Psychopharmacology: Clinical and Experimental, 34(5), e2710. https://doi.org/10.1002/hup.2710 Read source
  16. Volkow, N. D., Wang, G. J., Smith, L., Fowler, J. S., Telang, F., Logan, J., & Tomasi, D. (2015). Recovery of dopamine transporters with methamphetamine detoxification is not linked to changes in dopamine release. NeuroImage, 121, 20–28. https://doi.org/10.1016/j.neuroimage.2015.07.035 Read source
Written by
Jessica Miller is the Content Manager of Addiction Help

Editorial Director

Jessica Miller is the Editorial Director of Addiction Help. Jessica graduated from the University of South Florida (USF) with an English degree and combines her writing expertise and passion for helping others to deliver reliable information to those impacted by addiction. Informed by her personal journey to recovery and support of loved ones in sobriety, Jessica's empathetic and authentic approach resonates deeply with the Addiction Help community.

Reviewed by
  • Fact-Checked
  • Editor
Kent S. Hoffman, D.O. is a founder of Addiction Help

Co-Founder & Chief Medical Officer

Kent S. Hoffman, D.O. has been an expert in addiction medicine for more than 15 years. In addition to managing a successful family medical practice, Dr. Hoffman is board certified in addiction medicine by the American Osteopathic Academy of Addiction Medicine (AOAAM). Dr. Hoffman has successfully treated hundreds of patients battling addiction. Dr. Hoffman is the Co-Founder and Chief Medical Officer of AddictionHelp.com and ensures the website’s medical content and messaging quality.

Real Help. Real Recovery.

Compare centers, explore options and start your path to recovery today.

Find Treatment Now

"AddictionHelp.com is helping to make recovery available to EVERYONE!"

- Angela N.